CompletedPhase 4

Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication.

United States417 participantsStarted 2005-10

Plain-language summary

To evaluate the effect of tolterodine ER in conjunction with behavioral intervention on subject satisfaction in OAB subjects who were dissatisfied with their most recent antimuscarinic OAB medication therapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female subjects greater than or equal to 18 years of age * Overactive bladder symptoms for at least 3 months * Previously treated with antimuscarinic OAB medications Exclusion Criteria: * Participation in any professionally coached sessions (RN, NP, PA or PT) teaching behavioral interventions

What they're measuring

Subject satisfaction with treatment at week 16: Percentage of subjects reporting satisfaction with their current OAB treatment using the Patient Perception of Treatment Satisfaction Question

Trial details

NCT IDNCT00230789

SponsorPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2006-12

View on ClinicalTrials.gov More Urinary Incontinence trials